These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38230393)

  • 41. [Genetic variations in apoptosis genes are associated with acute adverse events in postoperative rectal cancer patients receiving concurrent chemoradiotherapy].
    Yin LL; Yang J; Feng YR; Huang Y; Feng T; Chen JN; Chen HX; Lin DX; Li YX; Jin J; Tan W
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):376-382. PubMed ID: 32482026
    [No Abstract]   [Full Text] [Related]  

  • 42. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 43. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation.
    Kumar T; Schernberg A; Busato F; Laurans M; Fumagalli I; Dumas I; Deutsch E; Haie-Meder C; Chargari C
    Cancer Manag Res; 2019; 11():6285-6297. PubMed ID: 31372035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma.
    Sun Y; Huang Z; Chi P
    Int J Clin Oncol; 2020 Jul; 25(7):1299-1307. PubMed ID: 32274615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy.
    Elicin O; Callaway S; Prior JO; Bourhis J; Ozsahin M; Herrera FG
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1099-107. PubMed ID: 25442041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mean cardiopulmonary dose and vertebral marrow dose differentially predict lineage-specific leukopenia kinetics during radiotherapy for esophageal cancer.
    Anderson JL; Newman NB; Anderson C; Sherry AD; Yock AD; Osmundson EC
    Radiother Oncol; 2020 Nov; 152():169-176. PubMed ID: 32291110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is the irradiated small bowel volume still a predictor for acute lower gastrointestinal toxicity during preoperative concurrent chemo-radiotherapy for rectal cancer when using intensity-modulated radiation therapy?
    Xu B; Guo Y; Chen Y; Lu H; Tang T; Yue Z; Guan G; Chi P; Lin C
    Radiat Oncol; 2015 Dec; 10():257. PubMed ID: 26684643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
    Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
    Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery.
    Toiyama Y; Inoue Y; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Saigusa S; Tanaka K; Mohri Y; Kusunoki M
    Int Surg; 2015 Feb; 100(2):199-207. PubMed ID: 25692418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Analysis of clinical predictive factors of pathologic complete response after neoadjuvant chemoradiotherapy in rectal cancer].
    Yu T; Cao XL; Wu GJ; Zhao G; Jia WW; Xiao G; Wang X
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(16):1274-7. PubMed ID: 27122460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk Analysis of Severe Thrombocytopenia in Nasopharyngeal Carcinoma During Concurrent Radio-Chemotherapy.
    Hu J; Tang L; Cheng Y; Liu A; Huang L
    Front Oncol; 2021; 11():754624. PubMed ID: 35186708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of longitudinal platelet count trajectory with ICU mortality: A multi-cohort study.
    Chen J; Gao X; Shen S; Xu J; Sun Z; Lin R; Dai Z; Su L; Christiani DC; Chen F; Zhang R; Wei Y
    Front Immunol; 2022; 13():936662. PubMed ID: 36059447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs.
    Tseng I; Ai D; Chen Y; Zhu H; Li F; Xu Y; Yu L; Liu Q; Deng J; Hao S; Zhu Z; Zhao W; Fan M; Li L; Su F; Zhao K
    Radiat Oncol; 2023 Oct; 18(1):172. PubMed ID: 37858121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical predictive value of short-term dynamic changes in platelet counts for prognosis of sepsis patients in intensive care unit: a retrospective cohort study in adults].
    Zhou Z; Xie Y; Feng T; Zhang X; Zhang Y; Jin W; Tian R; Wang R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Mar; 32(3):301-306. PubMed ID: 32385993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Use of Single-Agent Versus Multiple-Agent Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Rectal Cancer.
    Peponis T; Stafford C; Cusack J; Cauley C; Goldstone R; Berger D; Parikh A; Bordeianou L; Kunitake H; Francone T; Ricciardi R
    J Gastrointest Cancer; 2022 Sep; 53(3):557-563. PubMed ID: 34196936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship of irradiated bone marrow volume and neutropenia in patients undergoing concurrent chemoradiation therapy for cervical cancer.
    Antony F; Chalissery JR; Varghese KM; Gopu GP; Boban M
    J Cancer Res Ther; 2022; 18(6):1498-1503. PubMed ID: 36412400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pretreatment platelet count as a predictor for survival and distant metastasis in nasopharyngeal carcinoma patients.
    Chen YP; Chen C; Mai ZY; Gao J; Shen LJ; Zhao BC; Chen MK; Chen G; Yan F; Huang TY; Xia YF
    Oncol Lett; 2015 Mar; 9(3):1458-1466. PubMed ID: 25663931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of Hematologic Toxicity and Bone Marrow Compensatory Response in Head and Neck vs. Cervical Cancer Patients Undergoing Chemoradiotherapy.
    Vitzthum LK; Heide ES; Park H; Williamson CW; Sheridan P; Huynh-Le MP; Sirak I; Wei L; Tarnawski R; Mahantshetty U; Nguyen C; Mayadev J; Yashar CM; Sacco AG; Mell LK
    Front Oncol; 2020; 10():1179. PubMed ID: 32793487
    [No Abstract]   [Full Text] [Related]  

  • 60. Pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis.
    Zhou P; Zhang Y; Luo S; Zhang S
    Radiother Oncol; 2021 Dec; 165():103-118. PubMed ID: 34718055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.